This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD) was downgraded to a Hold Rating at Morgan Stanley

Tipranks - Tipranks - Fri Jun 19, 12:30AM CDT

Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh received a Hold rating and price target from Morgan Stanley analyst David Bailey today.

Claim 55% Off TipRanks

According to TipRanks, Bailey is a 4-star analyst with an average return of 6.3% and a 43.81% success rate. Bailey covers the Healthcare sector, focusing on stocks such as Ramsay Health Care, Telix Pharmaceuticals, and Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh.

Currently, the analyst consensus on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh is a Strong Buy with an average price target of A$41.27.

See the top stocks recommended by analysts >>

Based on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh’s latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of A$1.42 billion and a net profit of A$395.1 million. In comparison, last year the company earned a revenue of A$1.29 billion and had a net profit of A$365.04 million

Read More on AU:RMD:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).